✦ LIBER ✦

PCVII COST EFFECTIVENESS OF ADDING NIASPANTO ATORVASTATIN TREATMENT IN THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN PATIENTS WITH DYSLIPIDEMIA IN THE UK

✍ Scribed by W Berger; S Roze; WJ Valentine; AJ Palmer

Book ID: 119596652
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 66 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)65793-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo-P5:344 Cost-effectiveness of intensiv

Mo-P5:344 Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80MG versus 10MG in secondary cardiovascular prevention in the UK

✍ Taylor, D.C.A.; Pandya, A.; Thompson, D.; Chu, P.; Graff, J.; Drummond, M.; Laro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Cost-Effectiveness of Atorvastatin in th

Cost-Effectiveness of Atorvastatin in the Primary Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes in Canada

✍ Khoury, Hanane; Wagner, Monika; Merikle, Elizabeth; Johnson, Scott J.; Roberts, 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 545 KB

Cost-effectiveness of atorvastatin in th

Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: A French adaptation of CARDS

✍ Antoine Lafuma; Xavier Colin; Anne Solesse 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 279 KB

Cost-effectiveness of primary prevention

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

✍ M. Raikou; A. McGuire; H. M. Colhoun; D. J. Betteridge; P. N. Durrington; G. A. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 181 KB

Cost-Effectiveness Analysis of Atorvasta

Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

✍ Klimes, J.; Vocelka, M.; Dolezal, T.; Kruntoradova, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Represcription of Low-Dose Acetylsalicyl

Represcription of Low-Dose Acetylsalicylic Acid After Discontinuation in Patients Receiving Treatment for Secondary Cardiovascular Disease Prevention in the UK

✍ Martín-Merino, Elisa; Johansson, Saga; Nagy, Péter; Rodríguez, Luis A. García 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 306 KB